Cargando…

Enhanced Antitumor Efficacy of a Combination of CPT‐11, a New Derivative of Camptothecin, and Cisplatin against Human Lung Tumor Xenografts

The objective of this study was to evaluate the antitumor efficacy of combined use of 7‐ethyl‐10‐[4‐(1‐piperidino)‐1‐piperidino]carhonyloxycamptothecin (CPT‐11) and cisplatin (CDDP). The antitumor activities of CPT‐11, CDDP and their combination against 3 human lung tumor xenografts were estimated u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kudoh, Shinzoh, Takada, Minoru, Masuda, Noriyuki, Nakagawa, Kazuhiko, Itoh, Kazunobu, Kusunoki, Yohko, Negoro, Shun‐ichi, Matsui, Kaoru, Takifuji, Nobuhide, Morino, Hideo, Fukuoka, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1993
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919127/ https://www.ncbi.nlm.nih.gov/pubmed/8385085 http://dx.doi.org/10.1111/j.1349-7006.1993.tb02856.x

Ejemplares similares

Relationship between the Pharmacokinetics of Irinotecan and Diarrhea during Combination Chemotherapy with Cisplatin
por: Kudoh, Shinzoh, et al.
Publicado: (1995)

Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer
por: Masuda, Noriyuki, et al.
Publicado: (2010)

Determinants of Myelosuppression in the Treatment of Non‐small Cell Lung Cancer with Cisplatin‐containing Chemotherapy
por: Matsui, Kaoru, et al.
Publicado: (1996)

Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer.
por: Masuda, N., et al.
Publicado: (1993)

Enhancement of Tumor Radio‐response by Irinotecan in Human Lung Tumor Xenografts
por: Tamura, Kenji, et al.
Publicado: (1997)

A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group.
por: Masuda, N., et al.
Publicado: (1998)

CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer.
por: Fukuoka, M., et al.
Publicado: (1997)

Photodynamic Therapy With YAG-OPO Laser for Early Stage Lung Cancer
por: Kato, Harubumi, et al.
Publicado: (1997)

Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivative of camptothecin (CPT)
por: Bissett, D, et al.
Publicado: (2004)

A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B(12) in Japanese patients with solid tumours
por: Nakagawa, K, et al.
Publicado: (2006)

Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer
por: Takeda, K, et al.
Publicado: (1999)

Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancer
por: Hou, Lidan, et al.
Publicado: (2022)

Antitumor Effect of DX‐8951, a Novel Camptothecin Analog, on Human Pancreatic Tumor Cells and Their CPT‐11‐resistant Variants Cultured in vitro and Xenografted into Nude Mice
por: Takiguchi, Soichi, et al.
Publicado: (1997)

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer
por: Negoro, S, et al.
Publicado: (2003)

A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin
por: Schoemaker, N E, et al.
Publicado: (2002)

A Novel Preparation Method for Camptothecin (CPT) Loaded Folic Acid Conjugated Dextran Tumor-Targeted Nanoparticles
por: Zu, Yuangang, et al.
Publicado: (2011)

Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)
por: Yamamoto, N, et al.
Publicado: (2004)

Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer.
por: Matsui, K., et al.
Publicado: (1998)

Polysaccharopeptides derived from Coriolus versicolor potentiate the S-phase specific cytotoxicity of Camptothecin (CPT) on human leukemia HL-60 cells
por: Wan, Jennifer Man-Fan, et al.
Publicado: (2010)

Pharmacological Correlation between Total Drug Concentration and Lactones of CPT‐11 and SN‐38 in Patients Treated with CPT‐11
por: Sasaki, Yasutsuna, et al.
Publicado: (1995)

Review of the Management of Relapsed Small-Cell Lung Cancer with Amrubicin Hydrochloride
por: Kimura, Tatsuo, et al.
Publicado: (2011)

Protective Effects of Kampo Medicines and Baicalin against Intestinal Toxicity of a New Anticancer Camptothecin Derivative, Irinotecan Hydrochloride (CPT‐11), in Rats
por: Takasuna, Kiyoshi, et al.
Publicado: (1995)

Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase.
por: Takada, M., et al.
Publicado: (1996)

Successful Desensitization with Crizotinib after Crizotinib-induced Liver Injury in ROS1-rearranged Lung Adenocarcinoma
por: Ota, Takayo, et al.
Publicado: (2019)

Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
por: Yamada, M, et al.
Publicado: (2002)

Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.
por: Takada, M., et al.
Publicado: (1995)

Camptothecin Delivery via Tumor-Derived Exosome for Radiosensitization by Cell Cycle Regulation on Patient-Derived Xenograft Mice
por: Yang, Yiling, et al.
Publicado: (2022)

Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors
por: Gigliotti, Casimiro Luca, et al.
Publicado: (2017)

A case of primary small cell carcinoma of the liver that was treated with chemotherapy
por: Morikawa, Hiroyasu, et al.
Publicado: (2008)

Effects of the combination of camptothecin and doxorubicin or etoposide on rat glioma cells and camptothecin-resistant variants
por: Pavillard, V, et al.
Publicado: (2001)

Characterization of DNA Topoisomerase-1 in Spodoptera exigua for Toxicity Evaluation of Camptothecin and Hydoxy-Camptothecin
por: Zhang, Lan, et al.
Publicado: (2013)

Randomised trial for the prevention of delayed emesis in patients receiving high-dose cisplatin.
por: Matsui, K., et al.
Publicado: (1996)

Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status
por: Bras-Gonçalves, R A, et al.
Publicado: (2000)

CPT and Superstring
por: Ellis, John R., et al.
Publicado: (1996)

PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins
por: Zuco, Valentina, et al.
Publicado: (2015)

Current perspectives on camptothecins in cancer treatment.
por: Dancey, J., et al.
Publicado: (1996)

Production of camptothecin in cultures of Chonemorpha grandiflora
por: Kulkarni, A. V., et al.
Publicado: (2010)

The combination of olaparib and camptothecin for effective radiosensitization
por: Miura, Katsutoshi, et al.
Publicado: (2012)

Camptothecin-based nanodrug delivery systems
por: Wen, Yan, et al.
Publicado: (2017)

Chromatin determinants impart camptothecin sensitivity
por: Puddu, Fabio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7i680ocpaem3scd0vls1mfq48s